REX American Resources

REX · NYSE

$40.53+$0.08 (+0.20%)TodayMarket closed ·
Prev close $40.45

REX analyst rating

This isn't available right now. Refresh to try again.

The case for and against

Updated Feb 12, 2025

Bull case

REX American Resources Corp has demonstrated a strong financial performance, with revised FY24 revenue estimates increasing to $638 million and FY24 EBITDA projected at $94 million, reflecting the company's robust third-quarter results. The continuing focus on carbon-capture initiatives and potential diversification beyond ethanol could enhance future cash flows, thereby providing opportunities for shareholder returns. Moreover, the company's significant asset base, characterized by $365 million in cash and short-term investments and zero debt, positions REX favorably for further investments and growth.

Bear case

REX American Resources has experienced a significant decline in share performance, dropping approximately 14% since its 1Q earnings call, while projected FY25 revenues have decreased from $712 million to $701 million due to necessary pricing adjustments. The company faces multiple headwinds, including potential decreases in ethanol and animal-feed byproduct pricing, rising input costs driven by corn and natural gas prices, and susceptibility to supply disruptions from adverse weather conditions or regulatory changes. Furthermore, estimates for FY25 EBITDA have been reduced from $107 million to $89 million as a result of delays in carbon capture utilization and storage (CCUS) initiatives and regulatory uncertainties, signaling potential challenges ahead for the company's financial health.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.